Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA intradermal distribution study
NCT05585398Phase 1Completed
- Sponsor
- Merz
- Start
- Oct 2022
- Primary completion
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of incobotulinumtoxinA in hyperhidrosis (4 arms), sponsored by Merz. Primary endpoint: Area of anhidrosis on contralateral points of the forehead at Week 4. Started Oct 2022; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on NCT05585398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585398.